Clinical trials
Phase 2 Vascular Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 5 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 42 |
| Terminated | 6 |
| Unknown status | 4 |
| Withdrawn | 2 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 9 |
| Neuroscience Trials Australia | 3 |
| Brigham and Women's Hospital | 2 |
| Complexa, Inc. | 2 |
| Duke University | 2 |
| Emory University | 2 |
| Pulmovant, Inc. | 2 |
| Takeda | 2 |
| University of Minnesota | 2 |
| Abbott Medical Devices | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vascular Diseases | 58 |
| Cardiovascular Diseases | 37 |
| Heart Diseases | 20 |
| Hypertension | 13 |
| Cerebrovascular Disorders | 8 |
| Arterial Occlusive Diseases | 7 |
| Peripheral Arterial Disease | 7 |
| Atherosclerosis | 6 |
| Central Nervous System Diseases | 6 |
| Coronary Artery Disease | 6 |
Trials
Showing 26 to 50 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.